The acquisition expands Resmed’s clinical sleep health portfolio into an adjacent area of significant unmet need — the treatment of Restless Legs Syndrome.

Medtrade exhibitor Resmed and ŌURA, maker of a popular smart ring, are partnering to expand access to sleep health education and pathways to care.

Third quarter results for fiscal year 2026 at Medtrade exhibitor Resmed revealed a revenue increase of 11% to $1.4 billion.

The Medtrade prize went to sleep tech innovator SleepRes for its Kricket PAP, which uses the newly developed Kairos Positive Airway Pressure (KPAP) to treat OSA.

When it comes to POCs, the details matter. "We want to license to the manufacturers and enable them to have a product that does not look like everybody else.”

Resmed results showed a revenue increase of 11% to $1.4 billion. Income from operations increased 18%.